Tensions Rise as U.S. Restrictions on Iranian Delegation at the UNGA Intersect With Ongoing Sanctions-Induced Medical Shortages

President Donald Trump and Iranian President Masoud Pezeshkian are slated to appear at the 81st U.N. General Assembly in New York. While visas for the Iranian delegation were approved, the U.S. State Department has imposed “strict limits” on their movements, confining officials to their hotel and the U.N. headquarters. The United Nations, as host nation under a 1947 agreement, must generally facilitate entry for foreign representatives, but the United States argues that its security and policy concerns justify the additional controls.

Fox News (website)

Iran’s health system is grappling with severe medication shortages. Shahram Kalantari, head of the Iranian Pharmacists Association, said pharmacies cannot obtain alternatives for almost 800 medications because rising costs and limited foreign-currency access have crippled imports. Iran now manufactures more than 97 % of its medicines by volume, yet specialist drugs that require imported raw materials remain scarce. Over 18,000 private pharmacies are awaiting payment from insurers, with debts approaching 800 trillion rials (? $300 million). Patients such as “Sima,” a 35-year-old with kidney disease, describe having to under-dose or sell household goods to afford life-saving drugs.

CNNFox News (website)WPMI - Mobile NewsThe Guardian

The United Nations meeting occurs amid a seven-month conflict that began on Feb. 28, when U.S. and Israeli forces launched strikes against Iranian targets. The war has disrupted the Strait of Hormuz, reduced global oil flow, and intensified U.S. “maximum-pressure” sanctions that target Iran’s banking sector and oil revenues. In June, Iran’s Food and Drug Administration warned that Israeli airstrikes damaged more than 40 pharmaceutical facilities, further straining supply chains. Earlier this year, U.S. Treasury Secretary Scott Bessent announced a clamp-down on networks used to evade sanctions, adding “presumed denial” rules for certain license applications.

CNN

• ? 800 medications unavailable in Iranian pharmacies (Kalantari).

CNN

• 97 % of Iran’s medicine volume produced domestically (Mehdi Pirsalehi).

CNN

• 18,000 private pharmacies awaiting insurer payments (Kalantari).

CNN

• 800 trillion rials (~$300 million) owed to pharmacies (Kalantari).

CNN

• More than 40 pharmaceutical firms damaged by Israeli strikes (Mohammad Hashemi).

CNN

U.S. Food and Drug Administration spokesman Mohammad Hashemi linked the shortages to war-time damage to pharmaceutical factories and the broader sanctions regime.

CNN

• “For the Iranians, the limitation is going to be that there's going to be less access to the international press and less ability for them to essentially poke the Trump administration in the eye,” — Theo Wold, former acting assistant attorney general.

Fox News (website)

• “Sanctions can obstruct financing and international payments, reduce the willingness of foreign banks and suppliers to engage with Iranian purchasers, and complicate the procurement and importation of medicines, pharmaceutical inputs and manufacturing technology” — Peivand Bastani, Flinders University.

CNN

Patients in Tehran describe daily struggles to obtain essential drugs. Pharmacists report that even generic heart-medication and cholesterol-lowering pills have become “far more expensive,” while migraine treatments have “completely vanished” from shelves.

CNN

The convergence of diplomatic restrictions at the UNGA and the deepening humanitarian crisis shows how U.S. pressure on Iran operates on multiple fronts. Restrictions on the Iranian delegation aim to limit the regime’s public messaging, while sanctions and banking hesitancy impede the flow of medical supplies, exacerbating public-health risks. The situation underscores the tension between strategic objectives and unintended consequences for civilian populations.

CNN